Ann R. Falsey

Infectious Disease

1425 Portland Ave
Rochester, NY 14621

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 171 publications

Discriminating Bacterial From Nonbacterial Lower Respiratory Tract Infection Within Clinical Subgroups of Hospitalized Adults.

Discriminating Bacterial From Nonbacterial Lower Respiratory Tract Infection Within Clinical Subgroups of Hospitalized Adults.

Journal: The Journal of infectious diseases

Published: April 24, 2026

Triggering of viral and bacterial respiratory infection hospitalizations by traffic pollution exposure in a cohort of hospitalized adults.

Triggering of viral and bacterial respiratory infection hospitalizations by traffic pollution exposure in a cohort of hospitalized adults.

Journal: PloS one

Published: December 26, 2025

Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345.

Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: December 12, 2025

Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.

Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.

Journal: Vaccine

Published: December 11, 2025

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

Journal: Vaccine

Published: October 31, 2025

Association between COVID-19 vaccine efficacy and epidemic force of infection.

Association between COVID-19 vaccine efficacy and epidemic force of infection.

Journal: NPJ vaccines

Published: September 12, 2025

Clinical Features and Gene Expression Patterns in Adults Hospitalized With Respiratory Syncytial Virus and Human Metapneumovirus Infection.

Clinical Features and Gene Expression Patterns in Adults Hospitalized With Respiratory Syncytial Virus and Human Metapneumovirus Infection.

Journal: The Journal of infectious diseases

Published: July 16, 2025

Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.

Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.

Journal: Science advances

Published: July 04, 2025

The risk of cardiac disease events after respiratory syncytial virus disease: a systematic literature review and meta-analysis.

The risk of cardiac disease events after respiratory syncytial virus disease: a systematic literature review and meta-analysis.

Journal: European respiratory review : an official journal of the European Respiratory Society

Published: July 03, 2025

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.

Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials.

Journal: JAMA network open

Published: May 28, 2025

Burden and severity of respiratory syncytial virus infection in adults with cardiovascular diseases: A systematic literature review.

Burden and severity of respiratory syncytial virus infection in adults with cardiovascular diseases: A systematic literature review.

Journal: Progress in cardiovascular diseases

Published: April 18, 2025

Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years.

Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: April 16, 2025

Showing 1-12 of 171

Last Updated: 09/26/2026